| Literature DB >> 25919000 |
Xin-chang Zhang1, Xiu-ping Xu2, Wen-tao Xu3, Wen-zhen Hou3, Ying-ying Cheng3, Chang-xi Li4, Guang-xia Ni5.
Abstract
OBJECTIVE: Acupuncture has commonly been used in China, either alone or in combination with Western medicine, to treat sudden sensorineural hearing loss (SSHL). The purpose of this systematic review is to assess the efficacy and safety of acupuncture therapy for patients with SSHL.Entities:
Mesh:
Year: 2015 PMID: 25919000 PMCID: PMC4412536 DOI: 10.1371/journal.pone.0125240
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Fig 1Flow diagram of the trial selection process for this systematic review.
Characteristics of included RCTs.
| Study ID | Diagnostic criteria | NO.(M/F) | Interventions | Duration of treatment | Outcomes | ||
|---|---|---|---|---|---|---|---|
| T | C | T (Main acupoints) | C | ||||
| Chen 2010 | 2005 criteria | 30 (14/16) | 30 (15/15) | Electroacupuncture (SJ17, SI19, GB2)+WMCT | WMCT (Low molecular dextran, ATP, Coenzyme A, Nimodipine, Gold theragran) | 10 days | PTAC |
| Dong 2011 | 2005 criteria | 30 (17/13) | 30 (14/16) | Manual acupuncture (SI19, SJ17, GB20, LI4, SJ3, SJ5, GB43)+WMCT | WMCT (Ginkgo leaf injection, Mecobalamin, Prednisone, Hyperbaric oxygen) | 14 days | PTAC, Adverse event |
| Huang 2014 | 2005 criteria | 59 (33/26) | 53 (29/24) | Manual acupuncture(SJ17, SJ21, GB2, SJ5, LI4, ST36, SP6, KI3, LR3, GB44)+WMCT | WMCT (Prednisone, Ginaton injection, Hyperbaric oxygen) | 20 days | PTAC, Improvement of tinnitus and vertigo |
| Liang 2012 | 2005 criteria | 30 (16/14) | 30 (12/18) | Electroacupuncture (SJ21, SI19, GB2, SJ17, GB34, SJ5, SJ3, GB41)+WMCT | WMCT (Methylprednisolone, Alprostadil, Ganglioside, Ginaton injection, Batroxobin injection) | 4 weeks | PTAC |
| Luo 2009 | 2005 criteria | 30 (15/15) | 30 (15/15) | Electroacupuncture (GB2, SJ17, LI4, GB43, SJ3) | WMCT (Low molecular dextran, ATP, Coenzyme A, Nimodipine, Gold theragran) | 10 days | PTAC, Adverse event |
| Qiu 2012 | 1996 criteria | 28 (6/22) | 30 (10/20) | Electroacupuncture (SJ21, SI19, GB2, SJ17, SJ3, GB43)+WMCT | WMCT (Guanxinning injection, Ciwujia injection, Vitamin B12, Hyperbaric oxygen) | 20 days | PTAC, Adverse event |
| Wang 1998 | 1996 criteria | 50 (32/18) | 50 (40/10) | Manual acupuncture(SJ17, ST7, SJ21, SI19, GB2, SJ3)+WMCT | WMCT (Low molecular dextran, ATP, Coenzyme A, Vitamin B6) | 2 weeks | PTAC |
| Wang 2006 | 1996 criteria | 73 (44/29) | 57 (32/25) | Electroacupuncture (GB20, Gong xue acupoint, SJ17, SJ21, SI19)+WMCT | WMCT (Alprostadil, Vitamin B1, Vitamin B12, Vitamin C, Sibelium, Kang bing du kou fu ye) | 2 weeks | PTAC |
| Xu(1) 2013 | 2005 criteria | 30 (19/11) | 32 (20/12) | Electroacupuncture (SJ21, SI19, GB2, SJ17, LI4, SJ3, SJ5, GB43, LR3, SP6, DU20)+WMCT | WMCT (Steroid, Mecobalamin, Alprostadil, Ginkgo leaf injection, Hyperbaric oxygen) | 15 days | PTAC |
| Xu(2) 2013 | 2005 criteria | 30 (19/11) | 30 (16/14) | Electroacupuncture (Shen guan acupoint, SI19, GB2, SJ17, GB12)+WMCT | WMCT (Dexamethasone, Xue-shuan-tong injection, Mecobalamin, Vitamin B1, Hyperbaric oxygen) | 1 month | PTAC |
| Zhang 2009 | 1996 criteria | 23 (14/9) | 19 (11/8) | Manual acupuncture (Si zhong acupoint, tou nie acupoint, GB20, SJ17, SJ5)+WMCT | WMCT (Dexamethasone, Ginkgo-damole Injection, Sibelium, Hyperbaric oxygen) | 6 weeks | PTAC |
| Zhang 2013 | 2005 criteria | 29 (11/18) | 30 (16/14) | Manual acupuncture (SJ21, SJ19, SJ17,GB2, SJ3, GB43)+ WMCT | WMCT (Xue-shuan-tong injection, Honghua injection, | 2 weeks | PTAC |
Abbreviations: T, Treatment group; C, Control group; PTAC, Pure-tone audiometric change; WMCT, Western Medicine Comprehensive Treatment; 1996 criteria, 1996 Chinese Medical Association Otorhinolaryngology criteria; 2005 criteria, 2005 Chinese Medical Association Otorhinolaryngology criteria.
Fig 2Risk of bias for each individual RCT.
Red (-): high risk of bias; Yellow (?): unclear risk; Green (+): low risk of bias.
Fig 3Forest plot of dichotomous data outcomes: proportion of participants with absolute improvement in PTA ≥15 dB.
WMCT: western medicine comprehensive treatment.
Fig 4Forest plot of continuous data outcomes: mean change in hearing over all frequencies (dB).
WMCT: western medicine comprehensive treatment.
Fig 5Funnel plot of the comparison between acupuncture and WMCT for the outcome of those participants with absolute improvements in PTA ≥15 dB.
WMCT: western medicine comprehensive treatment.
GRADE evidence profile for the studies in the meta-analysis.
| Quality assessment | Quality of evidence | ||||||
|---|---|---|---|---|---|---|---|
| No of studies | Design | Risk of bias | Inconsistency | Indirectness | Imprecision | Other considerations | |
|
| |||||||
| 11 | randomized trials | serious | no serious inconsistency | no serious indirectness | no serious imprecision | reporting bias | ⊕⊕ΟΟLOW |
|
| |||||||
| 5 | randomized trials | serious | no serious inconsistency | no serious indirectness | serious | reporting bias | ⊕ΟΟΟVERY LOW |
|
| |||||||
| 6 | randomized trials | serious | no serious inconsistency | no serious indirectness | serious | reporting bias | ⊕ΟΟΟVERY LOW |
|
| |||||||
| 1 | randomized trials | serious | no serious inconsistency | no serious indirectness | serious | reporting bias | ⊕ΟΟΟVERY LOW |
|
| |||||||
| 3 | randomized trials | serious | serious | no serious indirectness | serious | reporting bias | ⊕ΟΟΟVERY LOW |
|
| |||||||
| 1 | randomized trials | serious | no serious inconsistency | no serious indirectness | serious | reporting bias | ⊕ΟΟΟVERY LOW |
|
| |||||||
| 2 | randomized trials | serious | serious | no serious indirectness | serious | reporting bias | ⊕ΟΟΟVERY LOW |
1Some studies had a high risk of bias due to their methodology;
2Total number of events is less than 300;
3The study had performance bias and detection bias;
4Only one study or two studies;
5I2 = 80%, considerable heterogeneity;
6I2 = 90%, considerable heterogeneity;
7All studies were from China;
WMCT: Western Medicine Comprehensive Treatment